Lorviqua25 (Lorlatinib Tablet) 25mg

Lorlatinib 25mg tablets are prescribed for treating certain types of non-small cell lung cancer. This oral medication belongs to the ALK inhibitor class and is used under medical supervision. Always follow your healthcare provider’s instructions when taking lorlatinib.

Strength

25mg

Pack Size

90s

Storage

Ambient

Manufacturer / TM Owner

PFIZER LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lorlatinib 25mg tablets are primarily used to treat non-small cell lung cancer that has spread to other parts of the body. It works by blocking abnormal signals in cancer cells, helping to slow or stop their growth. Patients often ask, what is lorlatinib used for, and it is specifically indicated for ALK-positive NSCLC after progression on other therapies. This medication is taken orally and is part of targeted cancer therapy.

Side Effects

Lorlatinib 25mg tablets may cause side effects such as fatigue, nausea, or changes in mood. Some users report mild headaches or digestive discomfort when starting treatment. These effects are generally temporary and should be discussed with a healthcare professional if they persist or worsen.

Precautions & Warnings

Store lorlatinib 25mg tablets at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Always handle with care and avoid crushing or splitting tablets unless instructed by a doctor. If you miss a dose, contact your healthcare provider for guidance.

Avoid Interactions

Lorlatinib may interact with other medications, including certain antidepressants, antifungals, or herbal supplements. Avoid grapefruit products while taking this medication, as they can increase side effects. Always inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using.

Frequently Asked Questions

Lorlatinib 25mg tablets are used to treat ALK-positive non-small cell lung cancer that has spread.

Store at room temperature in a dry place, away from direct sunlight and out of reach of children.

Lorlatinib can be taken with or without food, but consistency in timing is recommended.

Common side effects include fatigue, nausea, and mood changes; consult your doctor if they persist.

No, lorlatinib requires a prescription and should only be taken under medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.